• Je něco špatně v tomto záznamu ?

Prevalence of human papillomavirus infection in oocyte donors and women treated for infertility: An observational laboratory-based study

H. Jaworek, B. Zborilova, V. Koudelakova, J. Brezinova, J. Vrbkova, I. Oborna, M. Hajduch,

. 2019 ; 4 (-) : 100068. [pub] 20190704

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19035687

Objective: The aims of this study were to determine the prevalence of human papillomavirus (HPV) infection in women treated for infertility and oocyte donors, and to investigate the possible influence of HPV infection on reproductive outcomes. Study design: In this observational laboratory-based study, cervical swabs were collected from oocyte donors (n = 207), and women treated for infertility (n = 945) and analysed for the presence of high-risk HPV (hrHPV) genotypes using the cobas® 4800 HPV Test and PapilloCheck® HPV-Screening. Associations between hrHPV positive status and fertility outcome or socio-behavioral and health characteristics were evaluated using R statistical software. Results: HrHPV prevalence was significantly higher in oocyte donors than in women treated for infertility (28.0% vs. 16.1%, P <  0.001). Women who became pregnant spontaneously (19.6%) and women not treated with in vitro fertilization (IVF, 18.1%) were more frequently hrHPV positive than women treated with IVF (12.7%, P = 0.077). Despite the high prevalence of hrHPV in both oocyte donors and infertile women, no associations between hrHPV positive status and pregnancy or abortion rates were found in IVF treated women or in oocyte recipients. Moreover, no associations between hrHPV positive status and abortion rates were found in spontaneously pregnant women. Conclusion: Despite the high prevalence of hrHPV in both oocyte donors and infertile women, HPV infection did not influence the outcomes of assisted reproductive technology.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035687
003      
CZ-PrNML
005      
20210126132833.0
007      
ta
008      
191007s2019 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.eurox.2019.100068 $2 doi
035    __
$a (PubMed)31517300
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Jaworek, Hana $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, 77900, Czech Republic.
245    10
$a Prevalence of human papillomavirus infection in oocyte donors and women treated for infertility: An observational laboratory-based study / $c H. Jaworek, B. Zborilova, V. Koudelakova, J. Brezinova, J. Vrbkova, I. Oborna, M. Hajduch,
520    9_
$a Objective: The aims of this study were to determine the prevalence of human papillomavirus (HPV) infection in women treated for infertility and oocyte donors, and to investigate the possible influence of HPV infection on reproductive outcomes. Study design: In this observational laboratory-based study, cervical swabs were collected from oocyte donors (n = 207), and women treated for infertility (n = 945) and analysed for the presence of high-risk HPV (hrHPV) genotypes using the cobas® 4800 HPV Test and PapilloCheck® HPV-Screening. Associations between hrHPV positive status and fertility outcome or socio-behavioral and health characteristics were evaluated using R statistical software. Results: HrHPV prevalence was significantly higher in oocyte donors than in women treated for infertility (28.0% vs. 16.1%, P <  0.001). Women who became pregnant spontaneously (19.6%) and women not treated with in vitro fertilization (IVF, 18.1%) were more frequently hrHPV positive than women treated with IVF (12.7%, P = 0.077). Despite the high prevalence of hrHPV in both oocyte donors and infertile women, no associations between hrHPV positive status and pregnancy or abortion rates were found in IVF treated women or in oocyte recipients. Moreover, no associations between hrHPV positive status and abortion rates were found in spontaneously pregnant women. Conclusion: Despite the high prevalence of hrHPV in both oocyte donors and infertile women, HPV infection did not influence the outcomes of assisted reproductive technology.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Zborilova, Blazena $u Fertimed Ltd., Olomouc, 77600, Czech Republic.
700    1_
$a Koudelakova, Vladimira $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, 77900, Czech Republic.
700    1_
$a Brezinova, Jana $u Arleta IVF Ltd., Kostelec nad Orlici, 517 41, Czech Republic.
700    1_
$a Vrbkova, Jana $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, 77900, Czech Republic.
700    1_
$a Oborna, Ivana $u Fertimed Ltd., Olomouc, 77600, Czech Republic.
700    1_
$a Hajduch, Marian $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, 77900, Czech Republic. Cancer Research Czech Republic, Olomouc, 77900, Czech Republic.
773    0_
$w MED00200567 $t European journal of obstetrics & gynecology and reproductive biology: X $x 2590-1613 $g Roč. 4, č. - (2019), s. 100068
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31517300 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20210126132829 $b ABA008
999    __
$a ind $b bmc $g 1452347 $s 1074237
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 4 $c - $d 100068 $e 20190704 $i 2590-1613 $m European journal of obstetrics & gynecology and reproductive biology: X $n Eur J Obstet Gynecol Reprod Biol X $x MED00200567
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace